ATE453328T1 - Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials - Google Patents

Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials

Info

Publication number
ATE453328T1
ATE453328T1 AT04768179T AT04768179T ATE453328T1 AT E453328 T1 ATE453328 T1 AT E453328T1 AT 04768179 T AT04768179 T AT 04768179T AT 04768179 T AT04768179 T AT 04768179T AT E453328 T1 ATE453328 T1 AT E453328T1
Authority
AT
Austria
Prior art keywords
providing
coating material
resistant coating
improved formulation
juice resistant
Prior art date
Application number
AT04768179T
Other languages
English (en)
Inventor
Vic Young
Original Assignee
Mw Encap Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28686399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE453328(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mw Encap Ltd filed Critical Mw Encap Ltd
Application granted granted Critical
Publication of ATE453328T1 publication Critical patent/ATE453328T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
    • A23P20/10—Coating with edible coatings, e.g. with oils or fats
    • A23P20/105—Coating with compositions containing vegetable or microbial fermentation gums, e.g. cellulose or derivatives; Coating with edible polymers, e.g. polyvinyalcohol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/288—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Paints Or Removers (AREA)
AT04768179T 2003-08-27 2004-08-25 Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials ATE453328T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0320020.1A GB0320020D0 (en) 2003-08-27 2003-08-27 Improved formulation for providing an enteric coating material
PCT/GB2004/003623 WO2005020708A1 (en) 2003-08-27 2004-08-25 Improved formulation for providing an enteric coating material

Publications (1)

Publication Number Publication Date
ATE453328T1 true ATE453328T1 (de) 2010-01-15

Family

ID=28686399

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04768179T ATE453328T1 (de) 2003-08-27 2004-08-25 Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials

Country Status (6)

Country Link
US (2) US8846087B2 (de)
EP (1) EP1667533B2 (de)
AT (1) ATE453328T1 (de)
DE (1) DE602004024902D1 (de)
GB (1) GB0320020D0 (de)
WO (1) WO2005020708A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8658202B2 (en) 2001-04-25 2014-02-25 Western University Of Health Sciences Coated drug delivery formulations
GB0320020D0 (en) * 2003-08-27 2003-10-01 Mw Encap Ltd Improved formulation for providing an enteric coating material
EP1954770A4 (de) * 2005-11-29 2012-10-31 Ideal Cures Pvt Ltd Wässrige filmbeschichtungszusammensetzung mit natriumalginat und ihre herstellung
EP1837323A1 (de) * 2006-03-24 2007-09-26 SOLVAY (Société Anonyme) Verfahren zur Herstellung von 1,1,1,3,3-Pentafluoropropan
CN101896170A (zh) * 2007-11-13 2010-11-24 赫尔克里士公司 用于营养品和药物剂型的水分散性肠溶衣配制物
EP2448566A2 (de) 2009-07-02 2012-05-09 Hercules Incorporated Stabile formulierung mit magensaftresistenter schellack-beschichtung für nutrazeutische und pharmazeutische dosierformen
US20130115285A1 (en) * 2010-02-12 2013-05-09 Eric H. Van Ness Enteric coating compositions and methods of making and using the same
US20110269850A1 (en) * 2010-04-28 2011-11-03 Signorino Charles A Shellac enteric coatings
IT1401146B1 (it) * 2010-07-27 2013-07-12 Gnosis Spa Composizione comprendente shellac e/o un suo sale e sodio amido glicolato
US9492394B2 (en) * 2010-08-18 2016-11-15 Evonik Roehm Gmbh Gastric resistant pharmaceutical or nutraceutical formulation comprising one or more salts of alginic acid
WO2014032742A1 (en) * 2012-08-27 2014-03-06 Evonik Industries Ag Pharmaceutical or nutraceutical composition with sustained release characteristic and with resistance against the influence of ethanol
RU2015110825A (ru) * 2012-08-27 2016-10-20 Эвоник Индустрис Аг Устойчивая к действию желудочного сока фармацевтическая или нутрицевтическая композиция со стойкостью к влиянию этанола
WO2014136857A1 (ja) * 2013-03-08 2014-09-12 ライオン株式会社 コーティング組成物、コーティング製剤及びその製造方法
CN104394898B (zh) * 2013-05-02 2017-10-13 卡迪奥诺沃姆有限公司 球囊表面涂层
WO2014177221A1 (en) * 2013-05-02 2014-11-06 Cardionovum Gmbh Balloon surface coating
EP3102639B1 (de) 2014-02-05 2023-08-02 Sensient Colors LLC Oberflächenbehandeltes calciumcarbonat, verfahren zur herstellung davon und zusammensetzungen damit
US20170065528A1 (en) * 2014-03-03 2017-03-09 Sensient Colors Llc Alcohol-Resistant, Dose Dumping Protective Enteric Drug Film Coating
SG11202000445TA (en) * 2017-08-09 2020-02-27 Lion Corp Coating composition, coating film, and coating preparation and method for producing same
EP3473245A1 (de) 2017-10-20 2019-04-24 Veru Inc. Orales tamsulosinhydrochlorid mit kontrollierter freisetzung
EP3473244A1 (de) 2017-10-20 2019-04-24 Veru Inc. Orales tamsulosinhydrochlorid mit kontrollierter freisetzung
MX2020006460A (es) * 2017-12-22 2020-11-06 Chemocentryx Inc Compuestos de anillo 5,5 fusionado sustituido con diarilo como inhibidores de c5ar.
EP4171228A4 (de) * 2020-06-26 2024-07-31 Sensient Colors LLC Enterale beschichtungszusammensetzung und verfahren zur herstellung und verwendung davon
US20250041265A1 (en) * 2021-12-03 2025-02-06 Dsm Ip Assets B.V. New delivery system for vitamin c

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126320A (en) 1964-03-24 Enteric-coated tablets of dextran sul-
US3350329A (en) * 1967-02-01 1967-10-31 Gillespie Rogers Pyatt Co Inc Coating compositions, of shellac, melamine formaldehyde, and styrene-acrylate emulsions
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
AU466503B2 (en) † 1972-06-05 1975-10-30 Alza Corporation Osmotic dispenser
GB8308508D0 (en) 1983-03-28 1983-05-05 Ici Plc Detergent compositions
US4778749A (en) * 1984-06-01 1988-10-18 Karyon Technology, Inc. Tissue culture and production in permeable gels
US4769168A (en) 1985-08-05 1988-09-06 Colgate-Palmolive Company Low phosphate or phosphate free nonaqueous liquid nonionic laundry detergent composition and method of use
IE63321B1 (en) 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
DE3610952A1 (de) * 1986-04-02 1987-10-08 Hagen Batterie Ag Verfahren zum herstellen von akkumulatoren mit akkumulatorplattensaetzen und nach diesem verfahren hergestellter akkumulator
WO1995002339A1 (en) † 1993-07-14 1995-01-26 Opta Food Ingredients, Inc. Shellac dispersions and coatings, and method of making
US6083532A (en) * 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
KR100387245B1 (ko) * 1997-10-17 2003-08-19 일양약품주식회사 유산균의안정화를위한미세장용성코팅과립
CA2307887A1 (en) * 1997-10-31 1999-05-14 Monsanto Company Gellan gum tablet coating
KR19990072826A (ko) † 1998-02-26 1999-09-27 우재영 판크레아틴장용코팅과립의제조방법
EP0943242A1 (de) 1998-02-26 1999-09-22 Puratos N.V. Granuliertes Brotvergesserungmittel sowie ihre Verwendung zur Herstellung von Teigwaren
US6620431B1 (en) 2000-04-17 2003-09-16 Charles Signorino Shellac film coatings providing release at selected pH and method
JP2002193831A (ja) 2000-12-27 2002-07-10 Fancl Corp ヘム鉄含有経口用組成物
US6759058B1 (en) 2001-04-25 2004-07-06 Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences Enteric-coated proliposomal formulations for poorly water soluble drugs
KR100474945B1 (ko) * 2002-01-10 2005-03-10 알앤엘생명과학주식회사 젖소의 원유 중 체세포 감소용 및 유방염의 예방 또는치료용 조성물
GB0320020D0 (en) * 2003-08-27 2003-10-01 Mw Encap Ltd Improved formulation for providing an enteric coating material
EP2448566A2 (de) 2009-07-02 2012-05-09 Hercules Incorporated Stabile formulierung mit magensaftresistenter schellack-beschichtung für nutrazeutische und pharmazeutische dosierformen

Also Published As

Publication number Publication date
EP1667533B1 (de) 2009-12-30
US20140377313A1 (en) 2014-12-25
DE602004024902D1 (de) 2010-02-11
US8846087B2 (en) 2014-09-30
US9629802B2 (en) 2017-04-25
GB0320020D0 (en) 2003-10-01
EP1667533A1 (de) 2006-06-14
EP1667533B2 (de) 2013-07-31
WO2005020708A1 (en) 2005-03-10
US20070071821A1 (en) 2007-03-29

Similar Documents

Publication Publication Date Title
ATE453328T1 (de) Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials
MX2009006594A (es) Formulaciones de ph regulado y estables que contienen polipeptidos.
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
TW200732349A (en) Anti-OX40L antibodies and methods using same
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
EA200600065A3 (ru) Гидрофобные композиционные и сыпучие материалы, их применение
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
CY1113074T1 (el) Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
NO20054093L (no) Fremgangsmate for fremstilling av keramiske partikler
EA201692543A1 (ru) Антагонисты активина-actriia и их применение для стимулирования роста кости
DK1458760T3 (da) Indfangede bindingsproteiner som biosensorer
SG155947A1 (en) Compositions and methods for the diagnosis and treatment of tumor
DE602005014147D1 (de) Verfahren zur herstellung von hydrokolloiden
BRPI0508700A (pt) uso de sns-595, composição farmacêutica, e, pó liofilizado
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
TW200720256A (en) IL-12 modulatory compounds
DE102005001078A8 (de) Glaspulver, insbesondere biologisch aktives Glaspulver und Verfahren zur Herstellung von Glaspulver, insbesondere biologisch aktivem Glaspulver
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
TW200607863A (en) Immune modulating compounds from fungi
UA96627C2 (ru) Сухой экстракт из pelargonium sidoides ta pelargonium reniforme, способ его получения и продукты на его основе
ATE485330T1 (de) Fluoriertes polyetherpolyamin und herstellungsverfahren dafür
TW200626073A (en) Activated globular protein and its use in edible compositions
EA200701688A1 (ru) Замещённые пирролы, содержащие их композиции, способ получения и применение

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties